Suchergebnisse - "Feigin, Andrew"

PubPharm (5)

1

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD) : a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

enthalten in: The Lancet. Neurology | 2024

von Reilmann, R. | Anderson, K. | Feigin, A. | +61

2

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD) : a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

enthalten in: The Lancet. Neurology | 2019

von Reilmann, R. | McGarry, A. | Grachev, I. | +114

CommentIn: Lancet Neurol. 2019 Feb;18(2):131-133. - PMID 30563777

3

Pridopidine in treatment of Huntington's disease : beyond chorea?

enthalten in: The Lancet. Neurology | 2011

von Feigin, A.

CommentOn: Lancet Neurol. 2011 Dec;10(12):1049-57. - PMID 22071279

4

AAV2-GAD gene therapy for advanced Parkinson's disease : a double-blind, sham-surgery controlled, randomised trial

enthalten in: The Lancet. Neurology | 2011

von LeWitt, P. | Rezai, A. | Leehey, M. | +18

CommentIn: Lancet Neurol. 2011 Apr;10(4):290-1. - PMID 21419705

5

Differential diagnosis of parkinsonism : a metabolic imaging study using pattern analysis

enthalten in: The Lancet. Neurology | 2010

von Tang, C. | Poston, K. | Eckert, T. | +8

1
[1]